AKT1 and metabolic dysfunction-associated steatotic liver disease: KEGG enrichment analyses using the DAVID database revealed that these targets are primarily involved in the P13K–Akt signaling pathway and lipid and atherosclerosis, underscoring their relevance to MASLD pathogenesis (Figure 1E).